Myelin Oligodendrocyte Glycoprotein (MOG) (AA 35-55) Peptid
Kurzübersicht für Myelin Oligodendrocyte Glycoprotein (MOG) (AA 35-55) Peptid (ABIN6699467)
Target
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Protein Region
- AA 35-55
-
Hersteller Produkt- Nr.
- 000-001-m41
-
Hersteller
- Rockland
-
Verwendungszweck
- Myelin oligodendrocyte glycoprotein (MOG) Peptide
-
Aufreinigung
- Greater than 95% specific peptide.
-
Reinheit
- Greater than 95% specific peptide.
-
-
Myelin Oligodendrocyte Glycoprotein (MOG) peptide
MOG Reaktivität: Human, Rind (Kuh), Maus, Schwein, Ratte Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
-
Application Note: Myelin oligodendrocyte glycoprotein (MOG) Control Peptide is suitable for use in ELISA, Western Blot, Dot blot, PCA, and other assays. Control peptide should be used at 1.0 μg per 1.0 μL of antiserum in per assay. Specific conditions for reactivity should be optimized by the end user.
Other: Control peptide should be used at 1.0 μg per 1.0 μL of antiserum per assay.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
-
Reconstitution_Buffer: Restore with deionized water (or equivalent)
Reconstitution_Volume: 1.0 mL
-
Konzentration
- 1.0 mg/mL
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store vial at 2 - 8 ° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. Dilute only prior to immediate use.
-
Haltbarkeit
- 12 months
-
-
- MOG (Myelin Oligodendrocyte Glycoprotein (MOG))
-
Hintergrund
-
Synonyms: Myelin oligodendrocyte glycoprotein, MOG, control peptide, blocking peptide
Background: Myelin oligodendrocyte glycoprotein (MOG) is a minor constituent of the CNS myelin synthesized by oligodendrocytes and Schwann cells and is thought to mediate homophilic cell-cell adhesion among other roles. MOG, Myelin basic protein (MBP), and proteolipid proteins (PLP) are potential primary encephalitogenic target antigens in multiple sclerosis.
Target
-
